European Union 
Co-financing from the state budget Investment project information
Having unique competence in the manufacture of sterile drugs, Polfa Warszawa is a major investor in a biotechnological drug production plant currently under construction in Duchnice. The plant is the largest investment project in the history of Polpharma Group and will enable the company to join the exclusive community of innovative biological drug manufacturers.
The plant is being erected on a plot of land of 5.2 ha. The total area of the facilities will be 30,720 m2. The plant will serve to biosynthesize active substances and manufacture biotechnological drugs for injections (vials, pre-filled syringes and freeze-dried forms).
go back